Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial (Q34213067)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

Christian Torp-Pedersen

11

object named as

Christian Torp-Pedersen

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

object named as

Marco Metra

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Philip Poole-Wilson

1

object named as

Philip A Poole-Wilson

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

John G F Cleland

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Andrea Di Lenarda

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Peter Hanrath

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jacobus Lubsen

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Beatrix Lutiger

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Willem J Remme

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Armin Scherhag

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Allan Skene

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Carvedilol Or Metoprolol European Trial Investigators

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

362

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9377

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7-13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Composite outcomes in randomized trials: greater precision but with greater uncertainty?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913800-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)13800-7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34213067&oldid=2116347798"